Copyright
©The Author(s) 2022.
World J Clin Cases. Apr 16, 2022; 10(11): 3401-3413
Published online Apr 16, 2022. doi: 10.12998/wjcc.v10.i11.3401
Published online Apr 16, 2022. doi: 10.12998/wjcc.v10.i11.3401
Figure 2 Changes in short-term (within 3 mo) and mid-term (within 6 mo) serum uric acid levels.
A: Hyperuricaemia group (n = 32) before and after washed microbiota transplantation (WMT) treatment. Short-term after treatment and before treatment: 481.00 ± 99.85 vs 546.81 ± 109.64 μM, P = 0.001. Mid-term after treatment and before treatment: 483.00 ± 101.21 vs 504.00 ± 100.30, P = 0.596. Short-term after treatment and mid-term after treatment: 485.88 ± 107.80 vs 528.12 ± 111.89, P = 0.276; B: Normal uric acid group (n = 100) before and after WMT treatment. Short-term after treatment and before treatment: 326.62 ± 63.30 vs 322.80 ± 52.00 μM, P = 0.500. Mid-term after treatment and before treatment: 325.50 ± 101.03 vs 308.30 ± 70.28, P = 0.350. Short-term after treatment and mid-term after treatment: 325.50 ± 101.03 vs 309.10 ± 68.32, P = 0.301.
- Citation: Cai JR, Chen XW, He YJ, Wu B, Zhang M, Wu LH. Washed microbiota transplantation reduces serum uric acid levels in patients with hyperuricaemia. World J Clin Cases 2022; 10(11): 3401-3413
- URL: https://www.wjgnet.com/2307-8960/full/v10/i11/3401.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v10.i11.3401